PLA2G7 and coronary artery disorder: Importantly, we had previ-ously shown that the Lp(a) of patients with coronary artery disease carries significantly lower amounts of Lp-PLA2 mass that expresses lower catalytic efficiency compared with controls, a phenomenon which is not observed for the LDL-Lp-PLA2[30].